Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1671 1682
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18411722 | SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY | Non-Final OA | The Regents of the University of Michigan |
| 18210213 | METHODS OF DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18288765 | METHOD FOR DIAGNOSING ACTIVE TUBERCULOSIS AND PROGRESSION TO ACTIVE TUBERCULOSIS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18303229 | Rare Variants In Hematopoietic Stem Cells (HSC) And Hematopoietic Progenitor Cells (HPC) Associated With Somatic Alterations Of The Blood | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17783997 | ENHANCED DISEASE RESISTANCE OF MAIZE TO NORTHERN CORN LEAF BLIGHT BY A QTL ON CHROMOSOME 4 | Non-Final OA | KWS SAAT SE & Co. KGaA |
| 18606338 | Methods of Using Donor-Derived Cell-Free DNA to Distinguish Acute Rejection and Other Conditions in Liver Transplant Recipients | Non-Final OA | Northwestern University |
| 18251536 | RAPID IDENTIFICATION AND TYPING OF VIBRIO PARAHAEMOLYTICUS | Non-Final OA | Becton, Dickinson and Company |
| 17904568 | METHODS FOR DETECTING NTRK GENE FUSION USING RNA IN SITU HYBRIDIZATION | Final Rejection | THE GENERAL HOSPITAL CORPORATION |
| 17720005 | Methods and Systems for Labelling Nucleic Acids | Non-Final OA | IMEC VZW |
| 17641650 | NOVEL GENETIC MARKERS FOR POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF THE SAME | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18042434 | LAMP DETECTION OF SARS-COV-2 IN SALIVA FOR THE RAPID DIAGNOSIS OF COVID-19 | Final Rejection | CITY OF HOPE |
| 18550083 | METHODS FOR USING A HYPOMETHYLATING AGENT TO TREAT DISEASES AND DISORDERS BASED ON GENE MUTATION PROFILES | Non-Final OA | Celgene Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy